Who are we? Efarmes is a generic pharmaceutical company devoted to develop and manufacture generics for third parties all over the world. Efarmes Generics Company is part of Lacer Group. Our head offices, manufacturing site with EU cGMP’s and R&D area are in Barcelona. What we do? Efarmes Generics Company seeks partners that want to in-license and market the generics. Our partners are both multinational and local pharmaceutical companies on the five continents. Efarmes Generics Company offers tailored-made proposals such as full development and manufacturing of generic pharmaceutical products ready to be marketed by third parties under their own brand name, co-development of generic products, and contract manufacturing. How we do it? Efarmes Generics Company covers all levels from formulation to finished product delivery. Efarmes Generics Company currently supplies finished dosage forms to many key players all over the world. Our manufacturing site plant produced last year 24 M units (3.240 batches) with 99,9% Quality Control Conforming. Our Business Proposal Our main business model is the out license and supply of generic finished dosage forms. Our dossiers are in EU CTD format and ready to file. We have some MAs available in Europe. Dossiers ready to file: - Rasagiline (Parkinson’s diseases) - Alprazolam (Anxiolytic) - Deflazacort (Corticosteroid) - Modafinil (Narcolepsy) - Sildenafil (Erectil Dysfunction) - Pioglitazone (Diabetes) - Rivastigmine (Alzheimer diseases) Dossiers under development: - Olmersartan + Amlodipine + Hidroclorothiazide (Hypertension). Q2 2016 Bioequivalence studies on-going. - Tapentadol, retard tabs, (Neurophatic Pain). Dossier will be available in 2018. Products which are subject to patent are currently not offered or made available in countries where patents are in force. No orders or deliveries prior to the expiry date of valid patents are possible. Please, contact us on generics@efarmes.es